INSP Inspire Medical Systems, Inc.
Healthcare$43.84-2.01%ClosedMarket Cap: $1.26B
As of 2026-05-25
Valuation
P/E (TTM)
10.70
PEG
0.06
P/B
1.59
P/S
1.38
EV/EBITDA
16.52
DCF Value
$133.86
FCF Yield
7.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.8%
Operating Margin
5.6%
Net Margin
14.3%
ROE
18.0%
ROA
14.4%
ROIC
6.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $204.6M | 86.5% | $-1.1M | $-11.3M | $— | — |
| Q4 null | $269.1M | 86.6% | $46.1M | $136.1M | $— | — |
| FY null | $912.0M | 85.4% | $51.0M | $145.4M | $— | — |
| Q3 null | $224.5M | 85.8% | $9.6M | $9.9M | $— | — |
| Q2 null | $217.1M | 84.0% | $-3.3M | $-3.6M | $— | — |
| Q1 null | $201.3M | 84.7% | $-1.5M | $3.0M | $— | — |
| Q4 null | $239.7M | 85.0% | $31.9M | $35.2M | $— | — |
| FY null | $802.8M | 84.7% | $36.1M | $53.5M | $— | — |
| Q3 null | $203.2M | 84.1% | $14.3M | $18.5M | $— | — |
| Q2 null | $195.9M | 84.8% | $5.1M | $9.8M | $— | — |
| Q1 null | $164.0M | 84.9% | $-15.2M | $-10.0M | $— | — |
| Q4 2023 | $192.5M | 85.4% | $9.3M | $14.8M | $0.49 | — |